These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32049809)

  • 1. The renin-angiotensin system blockers and survival in digestive system malignancies: A systematic review and meta-analysis.
    Zhou Q; Chen DS; Xin L; Zhou LQ; Zhang HT; Liu L; Yuan YW; Li SH
    Medicine (Baltimore); 2020 Feb; 99(7):e19075. PubMed ID: 32049809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The renin-angiotensin system blockers as adjunctive therapy for cancer: a meta-analysis of survival outcome.
    Li XY; Sun JF; Hu SQ
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1375-1383. PubMed ID: 28387887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers as therapeutic options in the treatment of renal cancer: A meta-analysis.
    Asgharzadeh F; Hashemzehi M; Moradi-Marjaneh R; Hassanian SM; Ferns GA; Khazaei M; Avan A
    Life Sci; 2020 Feb; 242():117181. PubMed ID: 31863771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) on cancer recurrence and survival: a meta-analysis.
    Song T; Choi CH; Kim MK; Kim ML; Yun BS; Seong SJ
    Eur J Cancer Prev; 2017 Jan; 26(1):78-85. PubMed ID: 27158979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy and colorectal cancer: a systematic review and meta-analysis.
    Dai YN; Wang JH; Zhu JZ; Lin JQ; Yu CH; Li YM
    Cancer Causes Control; 2015 Sep; 26(9):1245-55. PubMed ID: 26081426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.
    Baral R; Tsampasian V; Debski M; Moran B; Garg P; Clark A; Vassiliou VS
    JAMA Netw Open; 2021 Mar; 4(3):e213594. PubMed ID: 33787911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review.
    Mc Menamin ÚC; Murray LJ; Cantwell MM; Hughes CM
    Cancer Causes Control; 2012 Feb; 23(2):221-30. PubMed ID: 22116540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with Optimal Dose Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Has a Positive Effect on Long-Term Survival in Older Individuals (Aged >70 Years) and Octogenarians with Systolic Heart Failure.
    Sargento L; Simões AV; Longo S; Lousada N; Dos Reis RP
    Drugs Aging; 2016 Sep; 33(9):675-83. PubMed ID: 27568454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of angiotensin-converting enzyme inhibitors and angiotensin receptors blockers in esophageal or gastric cancer patients with hypertension - a real-world study.
    Li PC; Huang RY; Yang YC; Hsieh KP; Yang YH
    BMC Cancer; 2022 Apr; 22(1):430. PubMed ID: 35443635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer.
    Blute ML; Rushmer TJ; Shi F; Fuller BJ; Abel EJ; Jarrard DF; Downs TM
    J Urol; 2015 Nov; 194(5):1214-9. PubMed ID: 26173101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials.
    Tai C; Gan T; Zou L; Sun Y; Zhang Y; Chen W; Li J; Zhang J; Xu Y; Lu H; Xu D
    BMC Cardiovasc Disord; 2017 Oct; 17(1):257. PubMed ID: 28982370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Incidence and Risk of Biochemical Recurrence Following Radical Radiotherapy for Prostate Cancer in Men on Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin Receptor Blockers (ARBs).
    Alashkham A; Paterson C; Windsor P; Struthers A; Rauchhaus P; Nabi G
    Clin Genitourin Cancer; 2016 Oct; 14(5):398-405. PubMed ID: 27053500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of renin-angiotensin system inhibitors on the survival of patients with rectal cancer.
    Zeman M; Skałba W; Wilk AM; Cortez AJ; Maciejewski A; Czarniecka A
    BMC Cancer; 2022 Jul; 22(1):815. PubMed ID: 35879682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have no beneficial effect on ablation outcome in chronic persistent atrial fibrillation.
    Zheng B; Kang J; Tian Y; Tang R; Long D; Yu R; He H; Zhang M; Shi L; Tao H; Liu X; Dong J; Ma C
    Acta Cardiol; 2009 Jun; 64(3):335-40. PubMed ID: 19593943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin system inhibitors and risk of fractures: a prospective cohort study and meta-analysis of published observational cohort studies.
    Kunutsor SK; Blom AW; Whitehouse MR; Kehoe PG; Laukkanen JA
    Eur J Epidemiol; 2017 Nov; 32(11):947-959. PubMed ID: 28752198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials.
    Zhang Y; He D; Zhang W; Xing Y; Guo Y; Wang F; Jia J; Yan T; Liu Y; Lin S
    Drugs; 2020 Jun; 80(8):797-811. PubMed ID: 32333236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin-angiotensin System Inhibitors and Development of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Asgharzadeh F; Jafarzadeh-Esfehani R; Hassanian SM; Ferns GA; Avan A; Khazaei M
    Curr Pharm Des; 2020; 26(39):5079-5085. PubMed ID: 32660400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective clinical study of renin-angiotensin system blockers in lung cancer patients with hypertension.
    Wei J; Zhou Z; Xu Z; Zeng S; Chen X; Wang X; Liu W; Liu M; Gong Z; Yan Y
    PeerJ; 2019; 7():e8188. PubMed ID: 31844581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibitors reduce mortality compared to angiotensin receptor blockers: Systematic review and meta-analysis.
    Salvador GL; Marmentini VM; Cosmo WR; Junior EL
    Eur J Prev Cardiol; 2017 Dec; 24(18):1914-1924. PubMed ID: 28862020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on insulin resistance in hypertensive patients: A protocol for a systematic review and meta-analysis.
    Yao J; Gong X; Shi X; Fan S; Chen J; Chen Q
    Medicine (Baltimore); 2020 Jun; 99(24):e20674. PubMed ID: 32541513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.